Phase II study of pembrolizumab-based therapy in previously treated extrapulmonary poorly differentiated neuroendocrine carcinomas: Results of Part A (pembrolizumab alone) Meeting Abstract

  

Authors:	Mulvey, C.; Raj, N. P.; Chan, J. A.; Aggarwal, R. R.; Cinar, P.; Hope, T. A.; Kolli, K.; Zhang, L.; Calabrese, S.; Grabowsky, J. A.; Modarresi, L.; Kelly, V.; Stonely, D.; Munster, P. N.; Reidy, D. L.; Fong, L.; Bergsland, E. K.
Abstract Title:	Phase II study of pembrolizumab-based therapy in previously treated extrapulmonary poorly differentiated neuroendocrine carcinomas: Results of Part A (pembrolizumab alone)
Meeting Title:	2019 Gastrointestinal Cancers Symposium
Journal Title:	Journal of Clinical Oncology
Volume:	37
Issue:	4 Suppl.
Meeting Dates:	2019 Jan 17-19
Meeting Location:	San Francisco, CA
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2019-02-01
Language:	English
ACCESSION:	WOS:000489107600392
DOI:	10.1200/JCO.2019.37.4_suppl.363
PROVIDER:	wos
Notes:	Meeting Abstract: 363 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/156142